ArticleFrontiers in immunology2026

Case Report: Ofatumumab for the treatment of refractory anti-NMDAR-positive autoimmune encephalitis.

Yekai Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.